SHMN
vs
S&P 500
SHMN
S&P 500
Over the past 12 months, SHMN has significantly outperformed S&P 500, delivering a return of +100% compared to the S&P 500's +21% growth.
Stocks Performance
SHMN vs S&P 500
Performance Gap
SHMN vs S&P 500
Performance By Year
SHMN vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SOHM Inc
Glance View
SOHM, Inc. engages in the manufacture and marketing of generic drugs. The company is headquartered in Buena Park, California. The company went IPO on 2006-10-11. The firm specializes in global trading of a product portfolio ranging from manufacturing, medical equipment, pharmaceuticals and chemicals. The company is focused on developing, manufacturing and distributing generic, branded generic, private label, and pharmaceuticals, cosmeceuticals and nutraceutical products. The company focuses on developing generic versions of brand-name products for which the patents are near expiration or expired. The company develops, manufactures, and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. Its product list includes analgesic, antibiotics, anti-cold, anti-flammatory, beta-lactum antibodies, capsules, drops, injections, suspension, syrup, tablets, vitamins and tones.
